Dubai: The Ministry of Health and Prevention, MoHAP, in partnership with the Mohammed Bin Rashid University of Medicine and Health Sciences, MBRU, has recently launched the Human Organs and Tissues Transplantation Center at Al Qassimi Hospital, Sharjah.
The announcement was made during MoHAP’s participation in the Arab Health 2020, which is being held at the Dubai World Trade Centre, January 27 – 30.
MoHAP’s first of its kind center has been fully equipped to keep pace with the latest international health standards and to achieve the UAE’s aspiration to be a role model, regionally and globally, in the field of human organs and tissues transplantation.
A Sustainable Solution
“The new center is one of the outcomes of the Federal Law No. (5) of 2016, issued by His Highness Sheikh Khalifa bin Zayed Al Nahyan, President of the UAE, with regard to the regulation of the transplantation of human organs and tissues to cope with the latest global health standards and develop a legislation system for organ transplantation. In addition, the Human Organs and Tissues Transplantation Center at Al Qassimi Hospital is part of the outcomes of the National Program for Organ Donation & Transplantation, launched by the UAE in 2018 to regulate and develop transplantation operations, ban human organs’ and tissues’ trafficking, regulate the process of donating organs and tissues, and prevent exploitation of the patient’s or the donor’s needs,” said H.E. Dr. Youssif Al Serkal, Assistant Undersecretary for the Ministry’s Hospitals Sector.
He noted that organ transplantation is a sustainable solution to a large number of patients, especially those with cancer, heart disease, pulmonary failure, hepatic fibrosis, and kidney failure diseases.
Fostering Medical Tourism
“The opening of this center would help enhance the government trends in terms of fostering medical tourism and picking up the pace of establishing a national organ bank, in addition to reinforcing the culture of donation and social awareness in that respect. This would help mitigate the pain of thousands of patients, alleviate the burden on hospitals, cut down financial costs borne by the country and society, and motivate insurance companies to launch new organ-transplantation-related packages,” Al Serkal concluded.
A Pioneering Position
Dr. Kalthoum Al Baloushi, Director of MoHAP’s Hospitals Administration said: “The new center for organ transplantation underlines the UAE’s quest to take a leading place in terms of promoting donation practices and organ and human tissues transplantation, thanks to the abundance of relevant resources including medical personnel, health facilities, and technological infrastructure, as well as international partnerships with the most prestigious international institutions to encourage scientific research in the field of organ transplantation.”
“The National Program for Organ Donation and Transplantation constitutes a sustainable solution to a large number of patients and it revives their hopes of survival as well. The new center is the UAE’s fifth facility in terms of organ transplantation licensed health facilities including; Sheikh Khalifa Medical City, Cleveland Clinic Hospital, Al Madinah Mediclinic Hospital, and Al Jalila Children's Hospital,” Al Baloushi concluded.
On a similar note, MoHAP is keen on implementing best international practices to ensure standardization of procedures nationwide, where the National Committee for Organ Transplantation has trained nearly 180 professionals from various medical authorities in the country.
-Ends-
© Press Release 2020Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
